Increased Copy Number (CN) of IQSEC1 occurred most frequently in advanced prostate cancers (Fig. 8b, CR, castrate-resistant; NE, neuroendocrine), associated with a gain in 3p Status (Fig. 8c; IQSEC1, 3p25.2-25.1). This evidence concerns the gene IQSEC1 and prostate cancer.